EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease

Xiuwei Ma, Lu Zhuang, Wenhao Ma, Jun Li iD, Yingying Mao, Jianhua Wang, Xiaodong Wang, Juan Xu, Shuangqing Yu, Ruijie Gu, Yongxia Wang, Zhongqiu Li und 16 weitere

New England Journal of Medicine · 2025

DOI: 10.1056/nejmoa2407766 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Xiuwei Ma und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing. Hauptthemen laut MEDLINE: alpha-Glucosidases, Dependovirus, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Peking University, National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-GlucosidasesDependovirusGenetic TherapyGenetic VectorsGlycogen Storage Disease Type IIChild, PreschoolHumansInfantMaleRespiratory Tract InfectionsInjections, IntravenousFollow-Up StudiesTreatment Outcome

Substanzen

alpha-GlucosidasesGAA protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing.
  • Department of Pediatric Medicine, Seventh Medical Center of Chinese PLA General Hospital, Beijing.
  • National Engineering Laboratory for Birth Defects Prevention and Control of Key Technology, Beijing.
  • Beijing Key Laboratory of Pediatric Organ Failure, Beijing.
  • Genecradle Therapeutics, Beijing.
  • Ultrasonic Department, Seventh Medical Center of Chinese PLA General Hospital, Beijing.

ORCID-Profile: Jun Li, Zhichun Feng

Förderung

  • Peking University
  • National Natural Science Foundation of China
  • National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital

Zitieren

APA

Ma, X., Zhuang, L., Ma, W., Li, J., Mao, Y., Wang, J., Wang, X., Xu, J., Yu, S., Gu, R., Wang, Y., Li, Z., Jiang, X., Zhang, S., He, F., Yang, X., Zhu, L., Zhang, S., Zhang, Y., …, & Feng, Z. (2025). AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2407766

Vancouver

Ma X, Zhuang L, Ma W, Li J, Mao Y, Wang J, et al. AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2407766

BibTeX
@article{Ma2025,
  author = {Ma, Xiuwei and Zhuang, Lu and Ma, Wenhao and Li, Jun and Mao, Yingying and Wang, Jianhua and Wang, Xiaodong and Xu, Juan and Yu, Shuangqing and Gu, Ruijie and Wang, Yongxia and Li, Zhongqiu and Jiang, Xinyang and Zhang, Sheng and He, Fang and Yang, Xiao and Zhu, Lina and Zhang, Shan and Zhang, Yanping and Li, Ting and Li, Qiuping and Wu, Zhijie and Zhang, Cengceng and Zhang, Yiying and Dong, Xiaoyan and Xiong, Hui and Wu, Xiaobing and Feng, Zhichun},
  title = {AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease},
  journal = {New England Journal of Medicine},
  year = {2025},
  doi = {10.1056/nejmoa2407766}
}
Kostenlos starten →